Head-to-head · WeighScore
Nava Health vs Neo Soma Healthcare
The verdict
Neo Soma Healthcare takes it — 65.8/100 to 60.6/100.
Neo Soma Healthcare grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Neo Soma Healthcare is a multi-product DTC telehealth platform pairing compounded GLP-1 weight management with sexual-health and anti-aging lines.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Nava Health | Neo Soma Healthcare |
|---|---|---|
| WeighScore | 60.6/100 | 65.8/100 |
| Grade | C | C |
| Scorecard rank | #319 | #213 |
| Semaglutide | Not disclosed | $199/mo |
| Tirzepatide | Not disclosed | $330/mo |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #319 · C
Strengths
- Integrative functional-medicine approach with advanced lab testing
- Both telemedicine and in-person options
- Board-certified MDs, DOs, NPs, PAs, and nutritionists
- Offers both brand and compounded GLP-1 formulations
- Financing and membership plans available
Where it loses points
- No published GLP-1 medication pricing online
- Consultation plus lab work adds to total cost
- Bundled integrative model costs more than medication-only platforms
- State availability for telehealth not clearly listed
Graded #213 · C
Strengths
- LegitScript verification badge present
- Publishes the FDA compounded-medication disclaimer
- Pricing shown publicly for all 6 product lines
- Multi-product platform (GLP-1, sexual health, peptide therapies)
- First-month discount on semaglutide ($99 entry)
Where it loses points
- Pharmacy partner not named (503A vs 503B unclear)
- States served not listed — no per-state availability table
- No named medical director
- Standard semaglutide pricing ($199/mo) above the cheapest providers ($150–180/mo)
- Tirzepatide entry pricing ($330) above the cheapest providers (~$200–250/mo)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.